Atavistik Bio Announces Publication in Science by Co-Founder Jared Rutter Describing Foundational Technology for its Atavistik Metabolite-Protein Screening (AMPS) Platform MIDAS (mass spectrometry integrated with equilibrium dialysis for the discovery of allostery systematically), in-licensed and industrialized by Atavistik Bio as the basis of AMPS, is the first...

National Big Data Challenge calls for students’ research into implications of recreational drug use TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- The Big Data Challenge on Recreational Drugs is mobilizing undergraduate students from across Canada to discover implications of alcohol, tobacco and...